左炔诺酮宫内缓释系统联合米非司酮治疗子宫腺肌病的近远期疗效分析

目的：探讨左炔诺酮宫内缓释系统（LNG-IUS）联合米非司酮治疗子宫腺肌病的近远期疗效及安全性。方法：将94例子宫腺肌病患者随机分为观察组（47例）和对照组（47例）,观察组放置LNG-IUS,同时服用米非司酮,每月1次,疗程为6个月。对照组仅放置LNG-IUS。观察两组疗程结束后、放置LNG-IUS后1、3、5年的临床疗效及不良反应。结果：疗程结束后,观察组和对照组总有效率分别为91.5%,87.2%,差异无统计学意义（P〉0.05）;随访期间,观察组的月经期、月经量、月经间期出血时间、不规则阴道流血或点滴出血的发生率均显著低于对照组,差异有统计学意义（P〈0.05）;观察组和对照组不良反应的发生率分别为21.3%和25.5%,差异无统计学意义（P〉0.05）。结论：LNG-IUS联合米非司酮治疗子宫腺肌病的近远期疗效确切,可有效减少不规则阴道出血。     

Long-term tillage effects on soil organic carbon and dissolved organic carbon in a purple paddy soil of Southwest China

The impact of conservation tillage practices on soil carbon has been of great interest in recent years. Conservation tillage might have the potential to enhance soil carbon accumulation and alter the depth distribution of soil carbon compared to conventional tillage based systems. Changes in the soil organic carbon (SOC) as influenced by tillage, are more noticeable under long-term rather than short-term tillage practices. The objective of this study was to determine the impacts of long-term tillage on SOC and dissolved organic carbon (DOC) status after 19 years of four tillage treatments in a Hydragric Anthrosol. In this experiment four tillage systems included conventional tillage with rotation of rice and winter fallow system (CTF), conventional tillage with rotation of rice and rape system (CTR), no-till and ridge culture with rotation of rice and rape system (NT) and tillage and ridge culture with rotation of rice and rape system (TR). Soils were sampled in the spring of 2009 and sectioned into 0–10, 10–20, 20–30, 30–40, 40–50 and 50–60 cm depth, respectively.Tillage effect on SOC was observed, and SOC concentrations were much larger under NT than the other three tillage methods in all soil depths from 0 to 60 cm. The mean SOC concentration at 0–60 cm soil depth followed the sequence: NT (22.74 g kg^?1) > CTF (14.57 g kg^?1) > TR (13.10 g kg^?1) > CTR (11.92 g kg^?1). SOC concentrations under NT were significantly higher than TR and CTR (P < 0.01), and higher than CTF treatment (P < 0.05). The SOC storage was calculated on equivalent soil mass basis. Results showed that the highest SOC storage at 0–60 cm depth presented in NT, which was 158.52 Mg C ha^?1, followed by CTF (106.74 Mg C ha^?1), TR (93.11 Mg C ha^?1) and CTR (88.60 Mg C ha^?1). Compared with conventional tillage (CTF), the total SOC storage in NT increased by 48.51%, but decreased by 16.99% and 12.77% under CTR and TR treatments, respectively. The effect of tillage on DOC was significant at 0–10 cm soil layer, and DOC concentration was much higher under CTF than the other three treatments (P < 0.01). Throughout 0–60 cm soil depth, DOC concentrations were 32.92, 32.63, 26.79 and 22.10 mg kg^?1 under NT, CTF, CTR and TR, and the differences among the four treatments were not significant (P > 0.05). In conclusion, NT increased SOC concentration and storage compared to conventional tillage operation but not for DOC.     

Phenylpropanoid constituents from the seeds of Lithocarpus pachylepis

Five phenylpropanoids including one new compound balanophonin A (1), one new natural compound balanophonin B (2) were isolated from the seeds of Lithocarpus pachylepis for the first time. Their structures were elucidated by various spectroscopic techniques (UV, IR, MS, CD, 1D and 2D NMR). All compounds were evaluated for their anti-inflammatory activities on lipopolysaccharide (LPS)-induced nitric oxide (NO) production in RAW 264.7.     

Tangshenosides from Codonopsis lanceolata roots

A new symmetrical phenylpropanoid glycoside, tangshenoside VIII (1), together with six known tangshenosides (2–7) were isolated from the roots of Codonopsis lanceolata (Campanulaceae). Their structures were established on the basis of spectroscopic data, including two-dimensional NMR analyses. Tangshenosides have chemotaxonomic significance.     

Triterpenoid saponins from Eryngium yuccifolium ‘Kershaw Blue’

Phytochemical investigation on the root of Eryngium yuccifolium ‘Kershaw Blue’ resulted in the isolation and identification of two new polyhydroxyoleanene saponins, named eryngioside M and eryngioside N, together with 15 known triterpenoid saponins eryngiosides A-L, 21β-angeloyloxy-3β-[β-d-glucopyranosyl-(1 → 2)]-[β-d-xylopyranosyl-(1 → 3)]-β-d-glucuronopyranosyloxyolean-12-ene-15α,16α,22α,28-tetrol, saniculasaponin III, and saniculasaponin II. Their structures were established by extensive spectroscopic and chemical analyses. Eryngioside M and saniculasaponin II showed week cytotoxicity against human non-small cell lung tumor cells (A549) with GI₅₀ values of 37.5 ± 1.59 μM and 35.5 ± 1.11 μM, respectively.     

Two new dianthramide glucosides with cardiomyocytes protective activity from Aconitum carmichaelii

Two new dianthramide glucosides, N-(2′-β-d-glucopyranosyl-5′-hydroxysalicyl)-4-hydroxy-3-methoxyanthranilic acid methyl ester (1) and N-(2′-β-d-glucopyranosyl-5′-hydroxysalicyl)-4-hydroxyanthranilic acid methyl ester (2), together with five known glycosides, were isolated from the lateral roots of Aconitum carmichaelii. Their structures were elucidated by spectroscopic analyses. In the in vitro assays, compounds 1 and 2 showed activity against pentobarbital sodium-induced cardiomyocytes damage by recovering beating rhythm and increasing the cell viability.     

Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate,LY2405319

Fibroblast growth factor 21 is a novel hormonal regulator with the potential to treat a broad variety of metabolic abnormalities, such as type 2 diabetes, obesity, hepatic steatosis, and cardiovascular disease. Human recombinant wild type FGF21 (FGF21) has been shown to ameliorate metabolic disorders in rodents and non-human primates. However, development of FGF21 as a drug is challenging and requires re-engineering of its amino acid sequence to improve protein expression and formulation stability. Here we report the design and characterization of a novel FGF21 variant, LY2405319. To enable the development of a potential drug product with a once-daily dosing profile, in a preserved, multi-use formulation, an additional disulfide bond was introduced in FGF21 through Leu118Cys and Ala134Cys mutations. FGF21 was further optimized by deleting the four N-terminal amino acids, His-Pro-Ile-Pro (HPIP), which was subject to proteolytic cleavage. In addition, to eliminate an O-linked glycosylation site in yeast a Ser167Ala mutation was introduced, thus allowing large-scale, homogenous protein production in Pichia pastoris. Altogether re-engineering of FGF21 led to significant improvements in its biopharmaceutical properties. The impact of these changes was assessed in a panel of in vitro and in vivo assays, which confirmed that biological properties of LY2405319 were essentially identical to FGF21. Specifically, subcutaneous administration of LY2405319 in ob/ob and diet-induced obese (DIO) mice over 7–14 days resulted in a 25–50% lowering of plasma glucose coupled with a 10–30% reduction in body weight. Thus, LY2405319 exhibited all the biopharmaceutical and biological properties required for initiation of a clinical program designed to test the hypothesis that administration of exogenous FGF21 would result in effects on disease-related metabolic parameters in humans.     

Comparison of the Efficiency of Banna Miniature Inbred Pig Somatic Cell Nuclear Transfer among Different Donor Cells

Somatic cell nuclear transfer (SCNT) is an important method of breeding quality varieties, expanding groups, and preserving endangered species. However, the viability of SCNT embryos is poor, and the cloned rate of animal production is low in pig. This study aims to investigate the gene function and establish a disease model of Banna miniature inbred pig. SCNT with donor cells derived from fetal, newborn, and adult fibroblasts was performed, and the cloning efficiencies among the donor cells were compared. The results showed that the cleavage and blastocyst formation rates did not significantly differ between the reconstructed embryos derived from the fetal (74.3% and 27.4%) and newborn (76.4% and 21.8%) fibroblasts of the Banna miniature inbred pig (P>0.05). However, both fetal and newborn fibroblast groups showed significantly higher rates than the adult fibroblast group (61.9% and 13.0%; P<0.05). The pregnancy rates of the recipients in the fetal and newborn fibroblast groups (60% and 80%, respectively) were higher than those in the adult fibroblast group. Eight, three, and one cloned piglet were obtained from reconstructed embryos of the fetal, newborn, and adult fibroblasts, respectively. Microsatellite analyses results indicated that the genotypes of all cloning piglets were identical to their donor cells and that the genetic homozygosity of the Banna miniature inbred pig was higher than those of the recipients. Therefore, the offspring was successfully cloned using the fetal, newborn, and adult fibroblasts of Banna miniature inbred pig as donor cells.